| Product Code: ETC8195362 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The large volume parenteral import shipments to Malta in 2024 continued to show high concentration with top exporting countries being India, Israel, Ireland, Germany, and Belgium. The Herfindahl-Hirschman Index (HHI) remained at a high level, indicating significant market concentration. With a Compound Annual Growth Rate (CAGR) of 10.1% from 2020 to 2024, the market is demonstrating steady growth. Furthermore, the impressive growth rate of 29.61% from 2023 to 2024 suggests a promising outlook for the large volume parenteral market in Malta.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Large Volume Parenteral Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Large Volume Parenteral Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Large Volume Parenteral Market - Industry Life Cycle |
3.4 Malta Large Volume Parenteral Market - Porter's Five Forces |
3.5 Malta Large Volume Parenteral Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Malta Large Volume Parenteral Market Revenues & Volume Share, By Volume, 2021 & 2031F |
3.7 Malta Large Volume Parenteral Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Malta Large Volume Parenteral Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Malta Large Volume Parenteral Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Malta Large Volume Parenteral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring parenteral administration of drugs |
4.2.2 Growing geriatric population in Malta leading to higher demand for large volume parenteral products |
4.2.3 Advancements in healthcare infrastructure and technology in Malta |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and quality standards for large volume parenteral products |
4.3.2 High production costs associated with manufacturing large volume parenteral solutions |
4.3.3 Limited availability of skilled healthcare professionals for administering large volume parenteral products |
5 Malta Large Volume Parenteral Market Trends |
6 Malta Large Volume Parenteral Market, By Types |
6.1 Malta Large Volume Parenteral Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Malta Large Volume Parenteral Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Malta Large Volume Parenteral Market Revenues & Volume, By Soft Bag LVP, 2021- 2031F |
6.1.4 Malta Large Volume Parenteral Market Revenues & Volume, By Plastic Bottle LVP, 2021- 2031F |
6.1.5 Malta Large Volume Parenteral Market Revenues & Volume, By Glass Bottle LVP, 2021- 2031F |
6.2 Malta Large Volume Parenteral Market, By Volume |
6.2.1 Overview and Analysis |
6.2.2 Malta Large Volume Parenteral Market Revenues & Volume, By 100 ml-250 ml, 2021- 2031F |
6.2.3 Malta Large Volume Parenteral Market Revenues & Volume, By 250 ml-500 ml, 2021- 2031F |
6.2.4 Malta Large Volume Parenteral Market Revenues & Volume, By 500 ml-1000 ml, 2021- 2031F |
6.2.5 Malta Large Volume Parenteral Market Revenues & Volume, By 1000 ml-2000 ml, 2021- 2031F |
6.2.6 Malta Large Volume Parenteral Market Revenues & Volume, By 2000 ml and more, 2021- 2031F |
6.3 Malta Large Volume Parenteral Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Malta Large Volume Parenteral Market Revenues & Volume, By Therapeutic Injections, 2021- 2031F |
6.3.3 Malta Large Volume Parenteral Market Revenues & Volume, By Fluid Balance Injections, 2021- 2031F |
6.3.4 Malta Large Volume Parenteral Market Revenues & Volume, By Nutritious Injections, 2021- 2031F |
6.4 Malta Large Volume Parenteral Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Malta Large Volume Parenteral Market Revenues & Volume, By Clinic, 2021- 2031F |
6.4.3 Malta Large Volume Parenteral Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.4 Malta Large Volume Parenteral Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Malta Large Volume Parenteral Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Malta Large Volume Parenteral Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Malta Large Volume Parenteral Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Malta Large Volume Parenteral Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Malta Large Volume Parenteral Market Import-Export Trade Statistics |
7.1 Malta Large Volume Parenteral Market Export to Major Countries |
7.2 Malta Large Volume Parenteral Market Imports from Major Countries |
8 Malta Large Volume Parenteral Market Key Performance Indicators |
8.1 Average length of hospital stay for patients receiving large volume parenteral treatments |
8.2 Number of hospitals and healthcare facilities offering large volume parenteral products |
8.3 Investment in research and development for innovative large volume parenteral solutions |
9 Malta Large Volume Parenteral Market - Opportunity Assessment |
9.1 Malta Large Volume Parenteral Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Malta Large Volume Parenteral Market Opportunity Assessment, By Volume, 2021 & 2031F |
9.3 Malta Large Volume Parenteral Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Malta Large Volume Parenteral Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Malta Large Volume Parenteral Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Malta Large Volume Parenteral Market - Competitive Landscape |
10.1 Malta Large Volume Parenteral Market Revenue Share, By Companies, 2024 |
10.2 Malta Large Volume Parenteral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here